Electronic prescribing reduced prescribing errors in a pediatric renal outpatient clinic

The Journal of Pediatrics
Yogini Hariprasad JaniIan Chi Kei Wong

Abstract

To assess the effect of an electronic prescribing (EP) system on the incidence and type of prescribing errors and the number of error-free visits. This was a before-and-after study conducted in a nephrology outpatient clinic at an acute tertiary care pediatric hospital. A total of 520 patients had 2242 items prescribed on 1141 prescriptions during the study period. The overall prescribing error rate was 77.4% (95% confidence interval [CI] = 75.3% to 79.4%) for handwritten items and 4.8% (95% CI = 3.4% to 6.7%) with EP. Before EP, 1153 (73.3%; 95% CI = 71.1% to 75.4%) items were missing essential information, and 194 (12.3%; 95% CI = 10.8% to 14%) were judged illegible. After EP, only 9 (1.4%; 95% CI = 0.7% to 2.6%) items were missing essential information, and illegibility errors were eliminated. The number of patient visits that were error-free increased from 21% to 90% (69% difference; 95% CI = 64% to 73.4%) after the implementation of EP. There was a high incidence of errors using handwritten prescriptions in the outpatient setting, with an overall error rate of 77.4%. EP significantly reduced errors related to completeness of prescriptions and eliminated legibility related errors.

References

Jan 22, 1997·JAMA : the Journal of the American Medical Association·T S LesarD S Stein
Sep 25, 2001·Archives of Pediatrics & Adolescent Medicine·R KaushalD W Bates
Feb 12, 2004·Journal of Perinatology : Official Journal of the California Perinatal Association·Leandro CorderoHagop S Mekhjian
Jul 3, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Ian C K WongNick Barber
Mar 10, 2005·JAMA : the Journal of the American Medical Association·Ross KoppelBrian L Strom
May 4, 2005·Journal of Pediatric Surgery·Jeffrey S UppermanEugene S Wiener
Oct 1, 2005·Quality & Safety in Health Care·M A GhalebI C K Wong
Dec 17, 2005·The Journal of Pediatrics·Heather A McPhillipsRobert L Davis
Apr 25, 2006·Pharmacoepidemiology and Drug Safety·Daniel S Budnitz, Peter M Layde
Jun 27, 2006·Journal of the American Medical Informatics Association : JAMIA·Emily M CampbellRichard H Dykstra

❮ Previous
Next ❯

Citations

Mar 28, 2012·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Norkasihan IbrahimYogini Jani
Jan 16, 2010·Pharmacy World & Science : PWS·Anna ChatsisviliIoannis Niopas
Dec 25, 2012·International Journal of Clinical Pharmacy·Sonia Prot-LabartheOlivier Bourdon
Jul 1, 2010·Patient Related Outcome Measures·Catherine E CookeDaniel A Belletti
Jul 21, 2012·Journal of the American Medical Informatics Association : JAMIA·Jeremy S Stultz, Milap C Nahata
Apr 25, 2009·Journal of the American Medical Informatics Association : JAMIA·C Jason WangDouglas S Bell
Nov 3, 2012·Pediatric Clinics of North America·Erika L Abramson, Rainu Kaushal
Nov 3, 2012·Pediatric Clinics of North America·Daniel R Neuspiel, Erin H Stubbs
Oct 19, 2010·International Journal of Medical Informatics·Christian SengerWalter E Haefeli
Apr 8, 2015·Research in Social & Administrative Pharmacy : RSAP·Pouyan Esmaeil Zadeh, Monica Chiarini Tremblay
Sep 9, 2011·The International Journal of Pharmacy Practice·Yogini Hariprasad JaniIan Chi Kei Wong
Nov 10, 2011·The Mount Sinai Journal of Medicine, New York·Joseph Kannry
Jun 1, 2010·The Laryngoscope·Rebecca RosenwasserPatrick J Antonelli
Mar 17, 2015·Worldviews on Evidence-based Nursing·Ömer GіderMehmet Top
Mar 24, 2016·International Journal of Clinical Pharmacy·Kim S J LaoIan C K Wong
Jan 22, 2008·The Journal of Pediatrics·Fiona Howard Levy
Jan 7, 2015·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Ahmed I AlbarrakRafiuddin Mohammed
Nov 1, 2017·Journal of the American Medical Informatics Association : JAMIA·Clare L TolleySarah P Slight
Apr 1, 2013·Therapeutic Advances in Drug Safety·Carolien M J van der LindenErik H M Korsten
Feb 26, 2020·International Journal of Clinical Pharmacy·Jian Lynn Lee
Jul 7, 2012·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Sandra BenavidesLeslie Briars
Mar 18, 2021·The International Journal of Pharmacy Practice·Conor Ming-Ho SinWa Keung Chiu
May 25, 2021·Hospital Pharmacy·Oluwaseun EgunsolaRahsid Hamoud Alnajrani
Aug 14, 2021·BMJ Quality & Safety·Yogini H Jani, Bryony Dean Franklin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.